Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neurotrope, Inc.NTRP · Entity 144906 | Director | March 13, 2018 | March 15, 2018 |
| XWELL, Inc.FH · Entity 1233 | Director · Chief Executive Officer | November 27, 2017 | November 28, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neurotrope, Inc.
Report date March 13, 2018 · Filed March 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.91 · Expires 2028-03-13 | Direct | 10,000 |
Reported balance
After 2018-03-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-13 · Grant · Acquired 10,000 · Balance 10,000 F1: Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy.
XWELL, Inc.
Report date November 27, 2017 · Filed November 28, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 428,578 |
Reported balance
After 2017-11-27 transaction · row 1
1 source rowRow 1 · 2017-11-27 · Purchase · Acquired 10,000 · Balance 428,578 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2018 Filed Mar 15, 2018 17:01 UTC | Neurotrope, Inc. NTRP · Entity 144906 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.91 | $0.00 |
DisclosureSEC source: 0001144204-18-014960 · tv488495_form4.xml · derivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-03-13 F1 · shares: Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 08:00 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 10,000 | $1.17 | $11,680.00 |
DisclosureSEC source: 0001144204-17-061046 · tv480266_4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,578 Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 09:15 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 10,000 | $1.36 | $13,570.00 |
DisclosureSEC source: 0001144204-17-048140 · v475245_4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,578 Read SEC document |
| August 18, 2017 Filed Aug 21, 2017 08:56 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 31,000 | $1.17 | $36,409.50 |
DisclosureSEC source: 0001144204-17-044271 · v473707_4.xml · nonDerivative · entry 2 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,578 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 08:56 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 42,000 | $1.16 | $48,867.00 |
DisclosureSEC source: 0001144204-17-044271 · v473707_4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,578 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 3,500 | $1.87 | $6,543.95 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 8 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,578 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 5,186 | $1.80 | $9,334.80 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 7 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,078 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 3,000 | $1.77 | $5,308.20 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 6 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,892 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 10,000 | $1.77 | $17,703.00 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 5 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,892 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 1,000 | $1.75 | $1,747.40 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 4 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,892 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 2,000 | $1.75 | $3,500.00 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 3 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,892 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 5,000 | $1.76 | $8,813.50 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 2 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,892 Read SEC document |
| May 23, 2017 Filed May 24, 2017 09:30 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 1,000 | $1.78 | $1,780.00 |
DisclosureSEC source: 0001144204-17-029197 · v467673_4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,892 Read SEC document |
| May 18, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 100 | $1.49 | $148.52 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 7 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,892 Read SEC document |
| May 17, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 1,000 | $1.65 | $1,649.90 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 6 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,792 Read SEC document |
| May 17, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 1,000 | $1.64 | $1,636.50 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 5 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,792 Read SEC document |
| May 17, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 1,000 | $1.63 | $1,625.20 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 4 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,792 Read SEC document |
| May 17, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 1,000 | $1.61 | $1,611.60 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 3 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,792 Read SEC document |
| May 17, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 2,000 | $1.61 | $3,222.40 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 2 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,792 Read SEC document |
| May 17, 2017 Filed May 19, 2017 10:05 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 25,000 | $1.57 | $39,275.00 |
DisclosureSEC source: 0001144204-17-028535 · v467437_form4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,792 Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 21:50 UTC | Neurotrope, Inc. NTRP · Entity 144906 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.10 | $0.00 |
DisclosureSEC source: 0001144204-17-015929 · v462252_4.xml · derivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-03-17 F1 · security: Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy. Such option grant is subject to stockholder approval of the Issuer's 2017 Equity Incentive Plan under which the option was granted. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 17:02 UTC | Neurotrope, Inc. NTRP · Entity 144906 | GrantStock Option (right to buy) · Derivative | 9,375 | $0.00 Strike: $15.77 | $0.00 |
DisclosureSEC source: 0001144204-17-010429 · v460082_4.xml · derivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 9,375 shares Expires 2027-02-17 F1 · shares: These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors and his service on the committees thereof. F2 · derivative.exercise_date: The stock options shall vest in equal daily installments over a five-year period beginning on the date of grant. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 17:36 UTC | XWELL, Inc. FH · Entity 1233 | GrantStock Option · Derivative | 300,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001144204-17-003250 · v456883_4.xml · derivative · entry 2 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2027-01-17 F3 · derivative.exercise_date: These options to purchase shares of common stock of the Issuer vest quarterly over 12 quarters starting March 31, 2017. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 17:36 UTC | XWELL, Inc. FH · Entity 1233 | GrantCommon Stock | 153,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-003250 · v456883_4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,792 F1 · shares: Represents 153,301 shares of restricted stock units which vest on the first year anniversary of the grant date. F2 · balance_after: Includes 153,301 shares of unvested restricted stock units. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 08:45 UTC | XWELL, Inc. FH · Entity 1233 | PurchaseCommon Stock | 23,250 | $2.16 | $50,173.50 |
DisclosureSEC source: 0001144204-16-123811 · v448739_form4.xml · nonDerivative · entry 1 Perlman Andrew D · CIK 0001493066 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,805 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.065 to $2.20, inclusive. The reporting person undertakes to provide to FORM Holdings Corp., any security holder of FORM Holdings Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.